Integer Holdings (ITGR) is back in focus after investors reacted to a recent Board initiated review of the business, growing interest in its diversified medical device portfolio, and plans to appear at a major MedTech conference.

Those Board level moves and upcoming MedTech conference appearances have arrived alongside a 1 month share price return of about 8% and a year to date share price return of about 21%. However, the 1 year total shareholder return is down about 23%, so near term momentum has improved while longer term returns remain more muted.

If this medical device stock has caught your attention, it can be useful to see what else is gaining interest in related areas, starting with 40 healthcare AI stocks

With Integer trading about 5% below average analyst price targets and an implied 31% discount to one intrinsic value estimate, the key question is whether this signals an undervalued medical device specialist or whether the market is already pricing in future growth.

Most Popular Narrative: 4.9% Undervalued

Integer Holdings' most followed narrative points to a fair value of about $97.56 versus the recent $92.74 share price, framing the stock as modestly undervalued on projected cash flows and earnings.

Tuck-in acquisitions and targeted capacity expansions such as the ramp-up of new facilities are compounding Integer's differentiated capabilities in high-growth portfolios like batteries and precision components for wearables and home healthcare, expanding its addressable market and driving future revenue and EPS growth.

Curious what has to happen for that valuation gap to close? The narrative leans on measured revenue growth, firmer margins, and a richer earnings multiple to tie it all together.

Result: Fair Value of $97.56 (UNDERVALUED)

However, investors still need to factor in risks such as revenue pressure if major OEM customers change buying patterns, as well as potential margin strain from industry pricing and cost headwinds.

Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

Next Steps

Mixed signals or emerging opportunity? With investors weighing both concerns and potential upside, it makes sense to review the numbers yourself and then check the 3 key rewards and 1 important warning sign.

Looking for more investment ideas?

If Integer is on your radar, do not stop there. Broaden your watchlist with stocks filtered for quality, resilience, and different types of potential returns.

• Target potential upside in companies that combine quality fundamentals with attractive pricing by scanning the 47 high quality undervalued stocks.
• Prioritise staying power and balance sheet strength by reviewing the solid balance sheet and fundamentals stocks screener (46 results) before the crowd catches on.
• Get ahead of the market by hunting for overlooked opportunities using the screener containing 22 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.